4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sysmex Corporation (6869) operates in the Medical Devices industry and is headquartered in Kobe, Japan with about 10,861 employees. Its market capitalization is roughly JPY 1.17 trillion. In the fiscal year ended 2026-03-31, 6869 reported JPY 500.0B in revenue and JPY 35.5B in net income.
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 500.0B | JPY 508.6B | JPY 461.5B | JPY 410.5B | — |
| Gross Profit | JPY 255.7B | JPY 272.0B | JPY 242.5B | JPY 216.1B | — |
| Operating Income (EBIT) | JPY 63.4B | JPY 90.8B | JPY 80.6B | JPY 76.0B | — |
| Net Income | JPY 35.5B | JPY 53.7B | JPY 49.6B | JPY 45.8B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 22.4B) | (JPY 18.1B) | (JPY 17.6B) | (JPY 16.5B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | JPY 707.5B | JPY 665.3B | JPY 618.9B | JPY 531.1B |
| Total Liabilities | JPY 201.9B | JPY 200.7B | JPY 186.0B | JPY 142.7B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6869 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms